Loading clinical trials...
Loading clinical trials...
Kymriah Real-world Effectiveness in ALL (KareALL): a Retrospective Chart Review Study of Tisagenlecleucel-treated ALL Patients
Conditions
Locations
1
United States
Novartis
East Hanover, New Jersey, United States
Start Date
March 1, 2023
Primary Completion Date
June 18, 2024
Completion Date
June 18, 2024
Last Updated
June 26, 2025
NCT06735690
NCT06074666
NCT04972942
NCT07523555
NCT07295951
NCT06395103
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions